Hybrid risk adjustment for pharmaceutical benefits
Year of publication: |
2009
|
---|---|
Authors: | García-Goñi, Manuel ; Ibern, Pere ; Inoriza, José |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 10.2009, 3, p. 299-308
|
Publisher: |
Springer |
Subject: | Clinical risk groups | Drug expenditure | Hybrid risk-adjustment | Morbidity |
-
Hybrid risk adjustment for pharmaceutical benefits
García-Goñi, Manuel, (2009)
-
Hybrid risk adjustment for pharmaceutical benefits
García-Goñi, Manuel, (2009)
-
Population based resource allocation: The use of hybrid risk adjustment
García-Goñi, Manuel, (2008)
- More ...
-
Estimates of patient costs related with population morbidity: Can indirect costs affect the results?
Carreras, M., (2009)
-
Predictability of drug expenditures: an application using morbidity data
García-Goñi, Manuel, (2008)
-
Estimates of patient costs related with population morbidity: Can indirect costs affect the results?
Carreras, M., (2009)
- More ...